Vimarsana
Biggest News Aggregation in the World

Pulse Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pulse Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pulse Bioscience Today - Breaking & Trending Today

Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting | Region - Vimarsana News

Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting | Region

HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024--

Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000 - Vimarsana News

Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that the Company’s Board of Directors has set the...

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results - Vimarsana News

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced business updates and financial results for the...

Pulse Biosciences Announces Plans to Initiate a Rights Offering - Vimarsana News

Pulse Biosciences Announces Plans to Initiate a Rights Offering

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that its Board of Directors has unanimously approved...

Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchases - Vimarsana News

Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchases

Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in company's expansion The...

Source: yahoo.com